MedPath

Clinical Study on Vataja Pratishayaya w.s.r. Allergic Rhinitis and its management with Gojivhadi Avaleha and Chitrak Haritaki Avaleha

Phase 3
Conditions
Health Condition 1: J309- Allergic rhinitis, unspecified
Registration Number
CTRI/2024/08/071794
Lead Sponsor
All India Institute of Ayurveda
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients of either sex aged between 3-12 years, and known cases of Allergic rhinitis as per the ARIA guidelines, will be included in the study.

(ARIA guidelines define allergic rhinitis as the presence of 2 or more recurrent symptoms of recurrent sneezing, watery nasal discharge, nasal congestion, nasal itching, and red itchy eyes, for at least one hour on most of the days or on most days of the season if symptoms are seasonal.)

2.Patients having signs and symptoms of Vataja Pratishyaya will be included in the

study.

Exclusion Criteria

1. Patients below 3 yr and above 12 yrs will be excluded.

2.Patients with a history of chronic debilitating diseases like Tuberculosis, Chronic Sinusitis, Nasal polypus, etc., and with other nasal pathology were excluded from the study.

3.Presence of fever, purulent nasal discharge.

4.Children suffering from any cases that require surgical intervention will be excluded.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Mean change in the CARAT (Control of Allergic Rhinitis and Asthma Test) Score <br/ ><br>[Time frame: Form baseline, at the end of 1st week, 2nd week, 3rd week, and at the <br/ ><br>end of 4th week] Annexure I <br/ ><br>Timepoint: 4 WEEKS
Secondary Outcome Measures
NameTimeMethod
1.Change in subjective and objective signs and symptoms of Vataja Pratishyaya. <br/ ><br>2.Mean change in the Laboratory investigations <br/ ><br> [Time frame: Form baseline and at the end of 4th week] <br/ ><br>Timepoint: 4 WEEKS
© Copyright 2025. All Rights Reserved by MedPath